G

Genetec Technology Bhd
KLSE:GENETEC

Watchlist Manager
Genetec Technology Bhd
KLSE:GENETEC
Watchlist
Price: 1.07 MYR 3.88% Market Closed
Market Cap: 843m MYR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one GENETEC stock under the Base Case scenario is 2.2 MYR. Compared to the current market price of 1.07 MYR, Genetec Technology Bhd is Undervalued by 51%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GENETEC Relative Value
Base Case
2.2 MYR
Undervaluation 51%
Relative Value
Price
G
Worst Case
Base Case
Best Case

Valuation Multiples

3.7
P/S
P/S
Price to Sales
3.7
vs History
60
vs Industry
36
Median 3Y
5.5
Median 5Y
4.8
Industry
2.7
Forward
3.2
More Details
21.9
P/E
P/E
Price to Earnings
21.9
vs History
53
vs Industry
32
Median 3Y
24.4
Median 5Y
24.3
Industry
22.6
Forward
14.7
More Details
59.8
P/OCF
P/OCF
Price to OCF
59.8
vs History
6
vs Industry
10
Median 3Y
22.4
Median 5Y
9.5
Industry
15.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
9
Median 3Y
-39.1
Median 5Y
-35
Industry
20.4
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
74
vs Industry
48
Median 3Y
4.1
Median 5Y
3.7
Industry
2
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
61
vs Industry
36
Median 3Y
5.3
Median 5Y
4.4
Industry
2.7
Forward
2.8
More Details
15.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
15.6
vs History
53
vs Industry
26
Median 3Y
16.7
Median 5Y
15.9
Industry
9
More Details
17.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.3
vs History
63
vs Industry
28
Median 3Y
19.5
Median 5Y
20.3
Industry
13.9
Forward
10.4
More Details
20.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.2
vs History
60
vs Industry
30
Median 3Y
20.7
Median 5Y
21.8
Industry
19
Forward
12
More Details
52.9
EV/OCF
EV/OCF
Enterprise Value to OCF
52.9
vs History
6
vs Industry
11
Median 3Y
21.1
Median 5Y
8.1
Industry
14.4
More Details
187.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
187.9
vs History
6
vs Industry
3
Median 3Y
30.8
Median 5Y
4.6
Industry
18.6
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
76
vs Industry
43
Median 3Y
4.8
Median 5Y
4.2
Industry
1.9
More Details

Multiples Across Competitors

GENETEC Competitors Multiples
Genetec Technology Bhd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
MY
Genetec Technology Bhd
KLSE:GENETEC
839.8m MYR 3.7 21.9 17.3 20.2
NL
ASML Holding NV
AEX:ASML
231.6B EUR 8.2 30.6 22.4 24.7
US
Brooks Automation Inc
LSE:0HQ1
225B USD 346.4 -1 390.8 7 819.2 -3 854.3
US
Applied Materials Inc
NASDAQ:AMAT
124.9B USD 4.5 19.7 14.4 15.1
US
KLA Corp
NASDAQ:KLAC
92.3B USD 8.5 28.8 20 21.8
US
Lam Research Corp
NASDAQ:LRCX
91.6B USD 5.3 19.7 15.9 17
JP
Tokyo Electron Ltd
TSE:8035
9.8T JPY 4.2 18.5 13.2 14.4
CN
NAURA Technology Group Co Ltd
SZSE:002371
241.7B CNY 8.7 44.1 38.2 38.2
JP
Advantest Corp
TSE:6857
4.4T JPY 6.5 32.4 20.3 23.4
NL
ASM International NV
AEX:ASM
21B EUR 7.2 30.6 20.1 25
JP
Disco Corp
TSE:6146
3.1T JPY 7.9 25.1 16.1 17.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
MY
G
Genetec Technology Bhd
KLSE:GENETEC
Average EV/EBIT: 21.7
20.2
4%
5.1
NL
ASML Holding NV
AEX:ASML
24.7
18%
1.4
US
B
Brooks Automation Inc
LSE:0HQ1
Negative Multiple: -3 854.3 N/A N/A
US
Applied Materials Inc
NASDAQ:AMAT
15.1
9%
1.7
US
KLA Corp
NASDAQ:KLAC
21.8
15%
1.5
US
Lam Research Corp
NASDAQ:LRCX
17
17%
1
JP
Tokyo Electron Ltd
TSE:8035
14.4
N/A N/A
CN
NAURA Technology Group Co Ltd
SZSE:002371
38.2
34%
1.1
JP
Advantest Corp
TSE:6857
23.4
N/A N/A
NL
ASM International NV
AEX:ASM
25
24%
1
JP
Disco Corp
TSE:6146
17.3
N/A N/A

See Also

Summary
GENETEC intrinsic value, competitors valuation, and company profile.
DCF Valuation
GENETEC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GENETEC stock valuation using valuation multiples.
Wall Street Estimates
GENETEC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GENETEC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 250,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.